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Abstract 
We recently reported the photodynamic inactivation (PDI) of bacteriophage MS2 with a 
photosensitiser- 5, 10, 15, 20-tetrakis (1-methyl-4-pyridinio) porphyrin- tetra- p-toluene 
sulfonate (TMPyP) in solution and concluded that the A-protein of the virus is the main 
target of inactivation. Here, we have extended these studies and carried out PDI of 
bacteriophage Yɴ, bovine enterovirus 2 (BEV-2) and type 1 murine norovirus (MNV-1). The 
rate of inactivation observed was in the order D^ ?ANYɴANDEs-1 > BEV-2.  Data suggested 
that TMPyP-treatment could also target the viral genome as well as result in 
disintegration/disassembly of viral particles. Although emergence of viral drug resistance is 
a well-documented phenomenon, it was not possible to generate PDI-resistant MS2. 
However, emergence of a mutation in the lysis protein was detected after serial exposure to 
PDI. 
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1. Introduction  
Photodynamic inactivation (PDI) of viruses has been shown to be a promising alternative 
antiviral strategy  (Casteel et al., 2004, Pecson et al., 2012, Silverman et al., 2013, Wainwright, 
2004, Costa et al., 2009, Costa et al., 2008, Costa et al., 2010). It is believed that Singlet oxygen 
and related reactive oxygen species (ROS) are responsible for the photodynamic inactivation 
of viruses (Costa et al., 2013). Among biomolecules, proteins have the highest bimolecular 
rate constant of singlet oxygen mediated oxidation (105 to 109 M-1 S-1) followed by RNA (104 
to 106 M-1 S-1) (Davies, 2003, Cho et al., 2010). Singlet oxygen and other ROS can only cause 
damage to molecules in close proximity because of their high reactivity and short half-life 
(Costa et al., 2013). Therefore, capsid proteins including host recognition proteins are 
immediate targets of singlet oxygen mediated oxidation in non-enveloped viruses, while 
envelope glycoproteins, including host-recognition proteins, are potential targets of singlet 
oxygen oxidation in enveloped viruses. In some cases, these proteins also act as host-
recognition proteins. However, capsid breathing of some non-enveloped viruses could allow 
small molecules into the capsid  (Dedeo et al., 2010, Valegård et al., 1990, Adeyemi et al., 
2017, Bothner et al., 2005, Jaegle et al., 1988, Jimenez-Clavero et al., 2000, Lewis et al., 1998, 
Pulli et al., 1998). This means that the viral genome could also be a target of PDI. Singlet 
oxygen can interact with potential targets either by physical quenching (which is only 
observed in tryptophan) and/or by chemical modification, which is observed in almost all 
amino acids. The chemical modification usually results in irreversible changes in amino acids 
with tryptophan, histidine, methionine, cysteine and tyrosine being most susceptible to 
singlet oxygen oxidation (Davies, 2003). 
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RNA viruses have high mutation rates that increases diversity within their populations and 
provides an enabling environment for adaptation (Duffy et al., 2008, Lauring et al., 2013, 
Domingo et al., 1996, Sanjuan et al., 2010, Irwin et al., 2016). Studies have reported on the 
emergence of resistant viruses upon continuous administration of antiviral drugs and 
exposure to common water disinfectants e.g. resistance of HIV to antiretroviral drugs (Hué et 
al., 2009), influenza virus to oseltamivir (Foll et al., 2014), hepatitis C virus to ribavirin 
(Feigelstock et al., 2011), bacteriophage MS2 and human echovirus 11 to chlorine dioxide 
(ClO2) (Zhong et al., 2016, Zhong et al., 2017), poliovirus and bacteriophage F116 to free 
chlorine (Bates et al., 1977b, Payment et al., 1985) and human echovirus 11 to Ultraviolet C 
(UVC) (Carratalà et al., 2017).  
Previously, we reported that a minimum dose of 0.2 µM TMPyP in solution under light (32 
mW cm-2) inactivated MS2 within one minute (Majiya et al., 2017). We also showed that the 
A-protein of MS2 was the PDI target and aggregation of the viral particles after sixty minutes 
of PDI treatment (Majiya et al., 2018). Although MS2 remains a useful and relevant virus for 
study, it is also necessary to investigate human (or closely related animal) viruses to accurately 
model inactivation of human viruses under relevant experimental conditions. A total of four 
non-enveloped, single strand positive sense RNA viruses were studied here (i.e. 
ďĂĐƚĞƌŝŽƉŚĂŐĞƐD^ ?ĂŶĚYɴ ?ďovine enterovirus type-2 (BEV-2) and type 1 murine norovirus 
(MNV-1)). Common among these viruses are 27-35 nm icosahedral capsids that include the 
most susceptible residues to ROS- mediated oxidation (Figure 1A), thereby making the viral 
capsids possible PDI targets. 
The MS2 capsid is made up of 178 copies of the coat protein (13.7 KDa) and one copy of the 
maturation or A-protein with which it binds the host bacterial pilus during infection (44 KDa) 
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(Dai et al., 2017, Koning et al., 2016). After-replication and assembly, the lysis protein allows 
the release of progeny virions from the infected cell (Walderich et al., 1988). dŚĞĐĂƉƐŝĚŽĨYɴ
is also composed of 178 copies of coat protein (13.7 KDa) and one copy of maturation protein 
(referred to as the A2-protein) which participates in host bacteria cell recognition and 
attachment to the bacterial pilus during infection (Gorzelnik et al., 2016). However, unlike 
MS2, It has been shown that coat protein subunits of Qɴ are linked by disulphide bonds to 
form covalent pentamers and hexamers (Takamatsu and Iso, 1982). The capsid of BEV-2 
comprises 60 copies each of VP1 (34 KDa), VP2 (29 KDa), VP3 (27 KDa) and VP4 (7 KDa) (Smyth 
et al., 1995, Goens et al., 2004). VP1, VP2 and VP3 are exposed on the surface of the capsid 
while VP4 is internal and myristylated at its N-terminal residue (Kaminaka et al., 1999, Smyth 
et al., 1995). The host attachment sites of BEV-2 are on the surface ridge, analogous to the 
canyon described in polioviruses and rhinoviruses (Smyth et al., 1995). MNV-1 capsids are 
formed from 180 copies of VP1 together with a small, but uncharacterised number of VP2 
proteins. Each copy of VP1 is divided into an N-terminal arm (N), a shell (S), and C-terminal 
protruding (P) domain (Taube et al., 2010, Katpally et al., 2010). The S and P domains are 
connected by a short hinge. The P domain forms arch-like dimers protruding from the capsid 
surface. It is subdivided into P1 (stem of the arch) and P2 (top of the arch) domains (Taube et 
al., 2010).  
To date, although there are several studies on the adaptation of viruses to antiviral drugs and 
disinfectants as well as the adaptation of gram-positive and gram-negative bacteria to sub-
lethal PDI conditions (Amin et al., 2016, Cassidy et al., 2010, Giuliani et al., 2010, 
Pourhajibagher et al., 2016a, Pourhajibagher et al., 2016b, Tavares et al., 2010, Zhang et al., 
2014), there are few reports on viral adaptation to PDI-treatment (Costa et al., 2011). There 
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is therefore a need for investigations of viral adaptation to PDI to inform decision, choice and 
design of PDI as an alternative antiviral agent. 
In this work, PDI-treatment of Yɴ, MNV-1 and BEV-2 were investigated using TMPyP in 
solution, while adaptation of MS2 to PDI was investigated at sub-lethal doses. Additionally, 
effects of PDI-treatment on encapsidated viral RNA was investigated using MNV-1. 
  
7 
 
2. Material and methods 
2.1 Light source, photosensitiser-TMPyP and conditions for PDI 
A Schott KL 2500 LCD (Schott Ltd., Stafford, UK), which provides a cool white light in the visible 
region of the spectrum (Figure 1B) was applied as the light source for the PDI experiments. 
The spectral properties of the light source was determined using a QE Pro, high sensitivity 
spectrometer, (Ocean Optics, USA). Fluence rates of illumination during photoinactivation 
experiments were measured using a light meter (Clas Ohlson, UK). Photosensitiser-TMPyP 
which has peak absorption within the visible region of the spectrum (Figure 1C) was 
purchased without further purification from Sigma Aldrich. Absorption spectra of TMPyP in 
phosphate buffered saline (PBS) (10 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, and 2.7 
mM KCl) was determined using a NanoDrop 2000C micro-spectrometer (Thermo Scientific) at 
20-22 oC under aerobic conditions and a light intensity of 32 mW cm-2. 
2.2 Virus strains and their host cells  
Stocks of bacteriophage MS2 and Qɴ and their E. coli host cells were a gift from Prof. P. 
Stockley University of Leeds, UK. Bovine enterovirus 2 (BEV-2) were provided by Prof. D. 
Rowlands, University of Leeds, UK. The murine norovirus (MNV-1), RAW 264.7 cells and rabbit 
anti-MNV capsid protein (VP1) polyclonal antibodies used in this study were kindly provided 
by Prof. I. Clarke (University of Southampton, UK). BL21 E. coli and BHK-21 cells were from 
standard laboratory stocks and rabbit anti-MS2 virus polyclonal antibodies were sourced 
commercially from Genscript, USA.  
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2.3 Propagation ĂŶĚƉƵƌŝĨŝĐĂƚŝŽŶŽĨďĂĐƚĞƌŝŽƉŚĂŐĞƐD^ ?ĂŶĚYɴ 
The bacteriophages D^ ? ĂŶĚ Yɴ ǁĞƌĞ ƉƌŽƉĂŐĂƚĞĚin E. coli and purified as previously 
described (Majiya et al., 2018). 
2.4 Propagation and purification of BEV-2 
BHK-21 cells were grown to 80-90% confluence according to standard procedures. Cells were 
infected with BEV-2 and incubated at 37 oC under 5% CO2 for 48 hours. Cells were lysed by 
freeze-thaw cycles and clarified by centrifugation at 1,431 xg for 10 minutes. Virus particles 
in the supernatant were precipitated using 50% (v/v) saturated ammonium sulphate at 4 oC 
overnight. The precipitate was pelleted by centrifugation at 1,430 xg for 30 minutes and re-
suspended in 10 ml PBS. Following a clarification step by centrifugation at 1,430 x g for 10 
minutes, supernatant was concentrated through a 30% (w/v) sucrose cushion by 
ultracentrifugation at 175,000x g for 3 hours using a Beckman SW 32 Ti rotor. The pellet was 
re-suspended in PBS and the virus purified through a 15 ?45% (w/v) sucrose gradient by 
ultracentrifugation at 160,000 x g for 2 hours using a Beckman SW 40 Ti rotor. Gradient 
fractions were collected from top to bottom and virus peak fractions were determined by 
SDS-PAGE (Weber and Osborn, 1969) followed by western blotting (Liu et al., 2014) using 
standard protocols. 
2.5 Propagation and purification of MNV-1 
RAW 264.7 cells were grown to 70-80% confluence according to standard procedures. Cells 
were infected with MNV-1 and incubated at 37 oC under 5% CO2 for 72 hours. Cells were lysed 
by freeze-thaw cycles and clarified three times by centrifugation at 1,431 xg for 10 minutes. 
The supernatant was harvested and virus particles concentrated through a 30% (w/v) sucrose 
cushion by ultracentrifugation at 175,000 xg for 3 hours using a Beckmann SW 32 Ti rotor. 
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The supernatant was discarded and pellet re-suspended in PBS. Re-suspended pellet was 
clarified by centrifugation at 13,000 rpm for 10 minutes and purified through a 15-60% 
sucrose gradient by ultracentrifugation at 300,000 xg for 50 minutes using a Beckmann SW 
55 Ti rotor. Gradient fractions were collected from top to bottom and virus peak fractions 
were determined by SDS-PAGE (Weber and Osborn, 1969) followed by immunoblotting 
against anti-MNV-1 VP1 using standard protocols (Liu et al., 2014). 
2.6 Photodynamic inactivation (PDI) of viruses  
A range of concentrations of TMPyP from 0.5 µM to 50 µM was applied at a light intensity of 
32 mW cm-2 for durations of illumination ranging from 10 seconds to 120 minutes. As controls, 
a dark experiment (D) was carried out in the presence of photosensitizer but without 
ŝůůƵŵŝŶĂƚŝŽŶ ?ǁŚŝůĞ “nŽƐĞŶƐŝƚŝƐĞƌ ? ?E^ )ĞǆƉĞƌŝŵĞŶƚƐǁĞƌĞĞǆƉŽƐĞĚƚŽůŝŐŚƚďƵƚŝŶƚŚĞĂďƐĞŶĐĞ
of photosensitiser. All experiments were repeated in triplicate. 
2.7 RNA transfection 
To assess the effect of PDI on the MNV genome, the RNA of TMPyP-treated MNV samples 
were extracted and purified using commercial Direct-Zol Miniprep Plus kits. Purified RNA was 
transfected into BHK-21 cells using Lipofectin reagent according to the recommended 
protocol. Transfected cells were incubated at 37oC under 5% CO2 for 48 hours. 
2.8 Virus titration assays 
To determine titre of ďĂĐƚĞƌŝŽƉŚĂŐĞƐ D^ ? ĂŶĚ Yɴ, double layer agar plaque assays were 
undertaken according to standard methods (Kropinski et al., 2009). To determine titre of BEV-
2, virus titres were determined by plaque assays were also used according to standard 
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procedures (Dulbecco and Vogt, 1954), while MNV titres were determined by TCID50 assays 
(Reed and Muench, 1938).  
2.9 Transmission electron microscopy 
TMPyP-treated and non-treated samples were each dialysed into buffer (10 mM Hepes, 100 
mM NaCl, 1.27 mM EDTA). Sample dialysates were negatively stained with 1% (w/v) uranium 
acetate and analysed by transmission electron microscopy according to standard methods 
(Humphrey, 2008, Stonehouse and Stockley, 1993). 
2.10 MS2 PDI and evolution experiment  
Our previously used and reported  PDI conditions of 0.5 µM TMPyP, 32 mW cm-2 and 30 sec 
illumination at 32 mW cm-2 which resulted to reductions of 4 log PFU/ml of MS2 from an initial 
titre of 9.6 log PFU/ml was used to select about 5 log PFU/ml of the MS2 populations still 
viable (Majiya et al., 2017). In order to test whether MS2 could evolve into PDI-resistant MS2, 
the viable populations were selected and then subjected to repeated cycles of same PDI 
conditions until the 10th cycle. After each treatment cycle, virus titres were determined by 
double layer agar plaque assays before and after TMPyP PDI-treatment.  
2.11 Viral genome extraction and sequencing 
In order to identify genetic changes, viral RNA was extracted and purified using Direct-Zol 
Miniprep Plus kits. Purified RNA genome was reverse-transcribed into cDNA using the 
SuperScript II commercial kit according to ŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ protocol. The cDNA was amplified 
by PCR using high fidelity Phusion® DNA polymerase (New England Biolab, UK) with a set 
primer of forward and reverse primers that covered the full genome of MS2. PCR products 
were purified using a Qiagen DNA gel extraction kit according to manufacturer ?s protocol and 
sequenced using genomic primers. PCR products were cloned into transient vector, pCRBlunt 
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 ?dŚĞƌŵŽ ĨŝƐŚĞƌ ^ĐŝĞŶƚŝĨŝĐ ? h^ ) ĂĐĐŽƌĚŝŶŐ ƚŽ ŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ ƉƌŽƚŽĐŽů. Plasmid was 
transformed into DH5ɲ E. coli cells and propagated in the presence of kanamycin. Colonies 
were screened for inserts by diagnostic digest using restriction-enzyme, EcoRI (New England 
Biologicals #3101). Positive colonies that contained the cloned inserts were sequenced using 
genomic primers. Primer sequences are available on request. 
 
 Results  
 
3.1 Abundance of PDI-susceptible residues on viral capsids  
PDI is a promising alternative antiviral strategy against enveloped (Käsermann and Kempf, 
1997) and non-enveloped viruses (Silverman et al., 2013). Studies have suggested that 
amongst the amino acids, tryptophan, histidine, methionine, cysteine and tyrosine are most 
susceptible to singlet oxygen mediated oxidation under physiological pH conditions (Davies, 
2003, Wilkinson et al., 1995, Gracanin et al., 2007). However, the abundance of these amino 
acids varies among viral capsid proteins. We therefore speculated that virus susceptibility to 
TMPyP-PDI may be a function of the abundance of these residues on the viral capsid as well 
as the singlet oxygen-accessibility to these residues. Estimating the abundance of these 
susceptible residues on the capsids of the viruses studied here, showed that MNV-1, MS2, 
BEV-2 and bĂĐƚĞƌŝŽƉŚĂŐĞYɴ possessed these susceptible amino acids in varying abundance 
(Figure 1A). 
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Figure 1: Spectral properties of PDI light source and absorption spectra of TMPyP, and 
amino acids most susceptible to singlet oxygen mediated oxidation among model viruses.  
(A) Percentage of the capsid protein residues that are most susceptible to PDI among the 
icosahedral viruses studied. Reference sequences of bacteriophages MS2 (NC_001417.2), and 
Yɴ ?z ? ? ? ? ? ? ? ? ) ?DEs-1 (KR349276.1) and BEV-2 (AY508697.1) were accessed from the NCBI 
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genebank and assessed for abundance of tryptophan, histidine, methionine, cysteine and 
tyrosine within the capsid region. Figure also shows the percentage abundance of a 
combination of all five amino acids susceptible to singlet oxygen mediated oxidation. (B), light 
spectra of our PDI light source (Schott KL 2500 LCD, Schott Ltd., UK). The PDI light source 
spectra (400 nm  ? 786 nm) showed that this mainly emitted visible light including some near 
infrared. The spectral peak is between 641 nm - 661 nm; (C), absorption spectra of the 
photosensitiser-TMPyP used for PDI of the viruses. The absorption peak of TMPyP is 422 nm. 
The TMPyP chemical structure was from ChemACX.com, ChemDraw Pro 13.0.  
 
3.2 PDI-treatment of Phage Yɴ, BEV-2 and MNV-1  
Previously, we showed that 0.5 µM TMPyP solution under illumination with light intensity of 
32 mW cm-2 caused complete inactivation of MS2 within 1 min (Majiya et al., 2017). Using 
these and other PDI conditions, we investigated the PDI of representative icosahedral viruses 
of the families Leviviridae  ?Yɴ), Picornaviridae (BEV-2) and Caliciviridae (MNV-1) as virus 
models to investigate mechanisms of PDI in non-enveloped viruses. Prior to PDI-treatment, 
the viruses were purified to prevent interference in PDI due to impurities that could quench 
the singlet oxygen (and other ROS) generated. In order to investigate PDI-inactivation of the 
viruses over time, purified virus samples were treated with up to 10 µM TMPyP and 32 mW 
cm-2 light. Our data suggested that the complete ŝŶĂĐƚŝǀĂƚŝŽŶŽĨYɴŽĐĐƵƌƌĞĚĂĨƚĞƌ ?ŵŝŶƵƚĞƐ 
(Figure 2A). Some reduction in titre of MNV and BEV was observed but with much higher 
concentrations of TMPyP and for longer time periods (up to 120 minutes) (Figure 2B and C).  
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Figure 2: PDI of icosahedral viruses over time. The samples were and illuminated at 32 mW 
cm-2. The figure shows PDI kinetics of (A), Qɴ Virus samples treated with 0.5 µM TMPyP; (B), 
MNV-1 treated with 5 µM and 10 µM TMPyP; (C), BEV-2 treated with 5 µM and 10 µM TMPyP.  
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The dark controls were treated with the concentration of photosensitiser shown but not 
illuminated whilst no photosensitiser controls (NS) were illuminated without photosensitiser 
present. n = 3 ± S.D.  
 
3.3 Effects of TMPyP-PDI on capsid integrity 
Previously, we showed that TMPyP-PDI may affect the integrity of the MS2 capsid and may 
result in aggregation of viral particles (Majiya et al., 2018). We therefore sought to investigate 
the structural effects of TMPyP PDI-treatment on the capsid integrity of other viruses using 
negative stain electron microscopy. Purified samples of Qɴ ?MNV-1 and BEV-2 were treated 
with 50 µM TMPyP for a range of durations from 1 minute to 60 minutes. Treated virus 
samples were negatively stained and viewed by TEM (Figure 3).  
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Figure 3: TEM of PDI treated model viruses with 50 µM TMPyP in solution.  Samples of Qɴ ?
MNV-1 and BEV-2 were purified through sucrose gradients and dialysed into TEM buffer as 
described in Methods. Dialysed virus samples were treated with 50 µM TMPyP and 
illuminated at 32 mW cm-2 for a range of durations from 1 minute to 60 minutes. As controls, 
 “ĂƌŬ ĞǆƉĞƌŝŵĞŶƚƐ ? ǁĞƌĞ ĂůƐŽ ƚƌĞĂƚĞĚ ǁŝƚŚ50 µM TMPyP but incubated for 60 minutes. 
Treated samples were immediately stained with 1% (w/v) uranyl acetate and visualised by 
TEM. Figure shows negatively stained TEM micrographs of Yɴ ? s-2 and MNV-1, 
respectively. Sample treatments are indicated on the right-hand panel. Scale bars are shown 
underneath each micrograph column. 
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Unlike previously reported aggregation of MS2 (Majiya et al., 2018) ?YɴĂŶĚs-2 did not 
show evidence of aggregation post- TMPyP PDI-treatment for up to 60 minutes. However, our 
data suggested some alterations to the appearance of the MNV-1 capsids following a short 
TMPyP PDI-treatment. Furthermore, no intact virions were detected after 30 minutes of PDI-
treatment and it is possible that the capsids had disassembled/disintegrated. 
3.4 Can the viral genome be affected by TMPyP-PDI? 
Owing to the capsid breathing phenomenon common to icosahedral viruses (Bothner et al., 
2005, Lewis et al., 1998, Jaegle et al., 1988, Witz and Brown, 2001), we previously suggested 
that there could be effects of PDI on inner residues of the viral capsid protein and the viral 
genome (Majiya et al., 2018). Here, using MNV-1 as a study model, we sought to investigate 
the effect of PDI on the encapsidated viral genome. Samples of MNV-1 were PDI-treated as 
previously described. Post-treatment, the viral genome was extracted and purified. For RNA 
viruses, the genome alone is infectious when introduced into susceptible cells. This 
phenomenon allows the analysis of the effects of PDI on the genome in the absence of the 
capsid. Here, the purified genomic RNA from PDI-treated viruses was transfected into 
susceptible cells and titrated for infectivity (Figure 4).   
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Figure 4: The effect of TMPyP-PDI treatment on RNA infectivity of MNV-1. Samples of MNV-1 were 
treated with 5 µM and 10 µM TMPyP and illuminated at 32 mW cm-2 for up to 20 minutes. Viral RNA 
was extracted from these samples and transfected into RAW 264.7 cells. Recovered viral infectivity 
titres were determined by TCID50 assays. ƐĐŽŶƚƌŽůƐ ? “dark ? samples were treated 10 µM TMPyP in 
the absence of light illumination, while  “no sensitizer ? samples (NS) were illuminated in the absence 
of TMPyP (n = 3 ± S.D.). 
 
The average titre of the viruses used here was approximately 7.3 log TCID50/ml (as shown in 
the data in Figure 2B). After RNA extraction, purification and transfection the titres were 
much reduced, as shown by the dark and no sensitizer control data in Figure 4. These loses 
were consistent throughout the experiment and suggest that the process viral RNA recovery, 
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as well as the transfection efficiency may have resulted to some loss of viral titres. However, 
RNA extracted from viruses that has been exposed to phototreatment with TMPyP yielded a 
further reduction in titre upon transfection. Furthermore, this decrease was dependent on 
both the TMPyP concentration and time of phototreatment (Figure 4). This demonstrates that 
PDI could also target the encapasidated viral genome of some viruses such as MNV-1. 
3.5 Selecting for TMPyP-PDI -resistant MS2 
We have previously reported that 0.5 µM TMPyP under light intensity of 32 mW cm-2 for 1 
minute, resulted in total inactivation of MS2. Here, we attempted to select TMPyP PDI-
resistant MS2 variants at this concentration but with light illumination for 30 seconds, which 
resulted to over 99.99% loss in viral titre (Majiya et al., 2017). After TMPyP-PDI treatment for 
30 seconds, surviving MS2 virus populations were recovered by passage. Cycles of PDI-
treatment followed by virus recovery were repeated for a total of ten cycles, and pre- and 
post-treated virus titres were determined by double layer agar plaque assays (Figure 5A). Viral 
RNA extracts from selection cycles 6 and 10 were reverse-transcribed, cloned into a transient 
vector (pCR-Blunt) and sequenced (Figure 5B). 
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Figure 5. Selection of PDI-resistant MS2. (A) Figure shows infectivity titre of MS2 before and 
after TMPyP-PDI treatment. Each PDI cycle was subjected to 0.5 µM TMPyP and illuminated 
at 32 mW.cm-2 for 30 seconds. As a control, a sample of MS2 was passaged serially in the 
absence of TMPyP for 10 cycles (n = 3±S.D.). (B) Viral genomic RNA was extracted from 
recovered passages 0, 6 and 10. RNA was reverse-transcribed into cDNA and cloned into 
transient vector pCR-Blunt. Colony clones of individual genomes of wild-type, TMPyP-PDI 
treated and non-treated cycle passages 6 and 10 were purified and sequenced. Sequence 
reads were aligned against reference MS2 sequence (NC_001417.2). Figure shows a cartoon 
annotation of the MS2 (NC_001417.2) genome. The cartoon shows open reading frames 
(ORFs) of the A-protein (red), coat protein (blue), lysis protein (green) and replicase (black). 
Mutations identified are listed below respective open reading frames. The mutation at 
nucleotide 1,697 resulted to a synonymous coat protein mutation (S121S), and a non-
synonymous lysis protein mutation (Q7P). 
 
21 
 
Throughout the PDI cycles, we consistently observed reductions of ~4 log10 PFU/ml over the 
10 cycles which indicates that no significant resistance to PDI had emerged in the MS2 
population (Figure 5A). Following selection, no phenotypic changes were observed. Despite 
this, we sought to investigate the occurrence of mutations at the genomic level within the 
population under selection and control viruses, passaged in the presence and absence of 
TMPyP selection. The 3.6 kbp MS2 genome encodes for a maturation protein (A-protein), coat 
protein, lysis protein and replicase (Figure 5B). Nucleotide changes were observed in both 
populations of viruses, as expected for RNA viruses. We will focus on the mutations that 
resulted in amino acid changes here. One of the viruses serially passaged in the absence of 
TMPyP-PDI treatment had a mutation in the A-protein (R83C, at the 6th passage). A different 
A-protein mutation (I238V) was observed in one of the viruses at the 10th passage, with 
R328W observed in a second virus (Figure 5B). Mutations R9M, M319I and H221R, also 
resulting in coding changes in the A protein, were observed in the PDI-treated viruses. None 
of the viruses sequenced had coding changes in the coat protein. However, because the lysis 
protein is produced in frameshift, non-synonymous mutations in the coat protein gene can 
result in lysis protein mutations. Indeed, a Q7P mutation was detected for all of the PDI-
treated viruses. (Figure 5B). 
4. Discussion 
The viruses used in this study have structural and genomic similarities being lytic, non-
enveloped, positive sense and single stranded RNA viruses with 27-35 nm icosahedral capsids. 
They have been employed as model organisms for this group of viruses in general. 
Furthermore, being members of the same family Leviviridae, MS2 and Yɴ share host bacteria 
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for replication. Despite these similarities, the rates of inactivation and physical changes to 
capsids, as induced by PDI, varied.   
Studies have shown that the rate and extent of inactivation of microorganisms is dose-
dependent on photosensitiser and duration of exposure (Casteel et al., 2004, Costa et al., 
2008, Costa et al., 2010, Costa et al., 2012).  The leviviriruses (MS2 and Yɴ) were the most 
susceptible to TMPyP PDI, respectively, followed by the calicivirus (MNV-1), while the 
picornavirus (BEV-2) was least susceptible to the TMPyP PDI-treatment. It is noteworthy that 
unlike MS2, the capsids ŽĨYɴŚĂǀĞĚŝƐƵůphide linkages (Takamatsu and Iso, 1982) that could 
contribute to the slower rate of inactivation as compared to MS2. It is also possible that lack 
of aggregation and Žƌ ĚŝƐŝŶƚĞŐƌĂƚŝŽŶ ŽĨ Yɴ ƉĂƌƚŝĐůĞƐ ĞǀĞŶ ĂĨƚĞƌ  ?0 minutes PDI-treatment 
could be due to the stability conferred on its capsid by the disulphide linkages. While MNV-1 
particles disintegrated under TMPyP-PDI treatment, we could not detect physical differences 
between the TMPyP-PDI treated and non-treated BEV-2 ŽƌYɴparticles by the transmission 
electron microscopy here. Additionally, the abundance of TMPyP PDI-susceptible amino acids 
on the capsid may play contributory roles if readily accessible. The lack of aggregation or 
disintegration of Yɴor BEV particles post-PDI treatment may have been influenced by their 
net surface charge. However, residues such as histidine, tryptophan and tyrosine are known 
to crosslink proteins when oxidised by singlet oxygen. (Davies, 2003, Shen et al., 2000b, Shen 
et al., 2000a, Carroll et al., 2017). Also, in some instances, secondary dark reactions have been 
implicated in the formation of protein crosslinks (Davies, 2003). 
RNA viruses rapidly evolve and therefore viruses with resistance to antiviral agents and 
disinfectants can arise when viruses are repeatedly exposed to sub-lethal doses of these 
agents (Carratalà et al., 2017, Bates et al., 1977a, Feigelstock et al., 2011, Foll et al., 2014, Hué 
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et al., 2009, Irwin et al., 2016, Zhong et al., 2016, Zhong et al., 2017). PDI is an efficient antiviral 
agent for viral control, with only one study reporting an attempt to select PDI-resistant viruses  
(Costa et al., 2011). Our unsuccessful attempt to select for TMPyP-PDI-resistant MS2 agrees 
with the previously reported study as to the lack of emergence of PDI-resistant viruses (Costa 
et al., 2011) and bacteria (Zhang et al., 2014, Tavares et al., 2010, Pourhajibagher et al., 2016b, 
Pourhajibagher et al., 2016a, Giuliani et al., 2010, Cassidy et al., 2010). However, within the 
quasi-species population of viruses sequenced in this study, some mutations identified within 
the A-protein (i.e. I238V, and R9M) as well as the lysis protein have been previously reported 
as conferring resistance against ClO2 following repeated exposure to this disinfectant (Zhong 
et al., 2016).  Since the MS2 lysis protein is essential to viral egress through the induction of 
host-cell lysis (Walderich et al., 1988), the emergence of the lysis protein mutation (Q7P) 
(Zhong et al., 2016) among TMPyP-PDI selected viruses suggests that sub-lethal doses of 
TMPyP in solution could target other stages of the viral life cycle. However, as no resistant 
viruses were selected, it is also possible that the mutations did not arise as a result of TMPyP 
treatment. 
5. Conclusion 
The results obtained in this work has shown that the chief determinant of rate and extent of 
PDI among viruses are the structure, amino acid composition and surface/solvent accessibility 
of their host attachment proteins/sites. This is at least true in non-enveloped viruses. Capsid 
proteins especially host attachment proteins/sites could be immediate targets of singlet 
oxygen oxidation in non-enveloped viruses such our model viruses. Therefore, the rate and 
ĞǆƚĞŶƚŽĨW/ŽĨŽƵƌŵŽĚĞůǀŝƌƵƐĞƐǁŝƚŚdDWǇWŝŶƐŽůƵƚŝŽŶŝŶƚŚĞŽƌĚĞƌD^ ?ANYɴANDEsAN
BEV, could be attributable in part to the abundance of amino acids that are susceptible to 
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singlet oxygen mediated oxidation and the solvent accessibility to these amino acids, together 
with possible effects on the RNA genome. Although selection of adaptive mutations were 
observed in this study, it was encouraging to note that MS2 resistance to PDI was not 
observed throughout the 10 PDI cycles. However, further investigation would be required to 
confirm these observations. 
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